Erythropoietin acts on hematopoietic stem cells in the bone marrow to stimulate blood cell production, and erythropoietin secretion decreases in CKD patients, which could be one of the reasons why the degree of PLT elevation at baseline was lesser in CKD patients than in non-CKD patients. Here, EPO is linked to chronic kidney disease.